About Us

Who We are

Cellix Bio is an innovative drug design and development biopharmaceutical company founded in May 2014. We aspire to develop best-in-class therapies for the treatment of neurological, inflammatory, metabolic, and other diseases. Using our proprietary technologies and strong “Synergix” scientific platform, we are developing new medicines that modulate more than one target in the disease pathway, which potentially improves efficacy and minimizes risk in the discovery and development process. We select drugs with demonstrated efficacy and clinical safety along targeted biological pathways, and then use our proprietary Synergix technology platform to produce new medicines that modulate those disease pathways with enhanced safety and efficacy.

%
Composition of Matter Patents
International Patents
Issued U.S.Patents
Pending U.S.Patents

WE’RE A COMPANY THAT TAKES ON THE TOUGHEST HEALTH CHALLENGES. WE DO MORE THAN TREAT DISEASES—WE AIM TO MAKE A REMARKABLE IMPACT ON PEOPLE’S LIVES. THE OVERARCHING CHALLENGE BEFORE US IS TO REDUCE COSTS WHILE WE IMPROVE DRUGS